Home Cart Sign in  
Chemical Structure| 93957-55-2 Chemical Structure| 93957-55-2

Structure of Fluvastatin Sodium Salt
CAS No.: 93957-55-2

Chemical Structure| 93957-55-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fluvastatin Sodium is a synthetic indole-heptanoic-acid-derived inhibitor of hepatic HMG-CoA reductase with IC50 of 8 nM.

Synonyms: Fluvastatin sodium; XU 62-320

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fluvastatin Sodium Salt

CAS No. :93957-55-2
Formula : C24H25FNNaO4
M.W : 433.45
SMILES Code : O=C([O-])C[C@@H](O)C[C@@H](O)/C=C/C(N1C(C)C)=C(C2=CC=C(F)C=C2)C3=C1C=CC=C3.[Na+]
Synonyms :
Fluvastatin sodium; XU 62-320
MDL No. :MFCD00929076

Safety of Fluvastatin Sodium Salt

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00256750 Kidney Transplantation ... More >> Chronic Kidney Failure Less << Phase 3 Completed - -
NCT01563731 Stroke Transi... More >>ent Ischemic Attack Hypertension Less << Phase 4 Recruiting November 2018 Russian Federation ... More >> Almazov Federal Heart, Blood and Endocrinology Centre Recruiting Saint-Petersburg, Russian Federation, 197341 Less <<
NCT01047501 Hypertriglyceridemia Phase 3 Completed - -
NCT01047683 Hypertriglyceridemia Phase 3 Completed - -
NCT00223054 - Completed - Germany ... More >> University of Schleswig-Holstein, Campus Kiel, Department of Nephrology Kiel, Germany, 24105 Less <<
NCT01890967 - Completed - -
NCT01492361 Cardiovascular Diseases Phase 3 Completed - -
NCT00132717 Hypercholesterolemia Phase 3 Completed - -
NCT01890967 Hypercholesterolemia Phase 2 Completed - -
NCT00256750 - Completed - -
NCT03510715 Hypercholesterolemia Phase 3 Recruiting June 2020 United States, California ... More >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 Less <<
NCT02107898 Hypercholesterolemia Phase 3 Completed - Japan ... More >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan Less <<
NCT03510884 Hypercholesterolaemia Phase 3 Recruiting March 2022 -
NCT02107898 - Completed - -
NCT01259791 Statin Myopathy Not Applicable Completed - Canada, Ontario ... More >> St. Joseph's Health Care London, Ontario, Canada, N6A 4V2 Less <<
NCT01514682 Schizophrenia Not Applicable Completed - United States, Maryland ... More >> Maryland Psychiatric Research Center Baltimore, Maryland, United States, 21228 Less <<
NCT00532311 Hypercholesterolemia Phase 3 Terminated(Overall profile of ... More >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) Less << - -
NCT00673660 - Completed - Turkey ... More >> Pfizer Investigational Site Mecidiyekoy, Istanbul, Turkey, 34394 Pfizer Investigational Site Bolu, Turkey Pfizer Investigational Site Haseki/Istanbul, Turkey, 34390 Pfizer Investigational Site Istanbul, Turkey, 34098 Pfizer Investigational Site Istanbul, Turkey Less <<
NCT01514682 - Completed - -
NCT00673660 - Completed - -
NCT00396110 - Completed - -
NCT01257971 - Completed - Croatia ... More >> Research Site Biograd na moru, Croatia Research Site Bjelovar, Croatia Research Site Cakovec, Croatia Research Site Crikvenica, Croatia Research Site Dubrovnik, Croatia Research Site Gospic, Croatia Research Site Karlovac, Croatia Research Site Koprivnica, Croatia Research Site Krapina, Croatia Research Site Krapinske toplice, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Porec, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Research Site Sisak, Croatia Research Site Slavonski brod, Croatia Research Site Split, Croatia Research Site Stubicke toplice, Croatia Research Site Umag, Croatia Research Site Vinkovci, Croatia Research Site Virovitica- Slatina, Croatia Research Site Virovitica, Croatia Research Site Vukovar, Croatia Research Site Zadar, Croatia Research Site Zageb, Croatia Research Site Zagreb, Croatia Less <<
NCT00726362 - Completed - Taiwan ... More >> Research Site Changhua, Taiwan Research Site Hualien, Taiwan Research Site Kaohsiung, Taiwan Research Site Pingtung, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Yun-Lin, Taiwan Less <<
NCT01293097 Non-ST Segment Elevation Myoca... More >>rdial Infarction Unstable Angina Pectoris Stable Angina Pectoris Less << Phase 4 Completed - China ... More >> Division of Cardiology, Peking University First Hospital Beijing, China, 10034 Less <<
NCT00127218 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Unversity School of Medicine Baltimore, Maryland, United States, 21218 Less <<
NCT02518503 - Completed - -
NCT01634906 Hyperlipidemia ... More >> Atherosclerosis Less << Not Applicable Completed - Netherlands ... More >> Sint Franciscus Gasthuis Rotterdam, Zuid Holland, Netherlands, 3004 BA Less <<
NCT02518516 - Completed - Canada, British Columbia ... More >> Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 Less <<
NCT01715714 Coronary Artery Disease Phase 4 Recruiting December 2019 Germany ... More >> Heart Center Freiburg-Bad Krozingen Active, not recruiting Freiburg, Baden-Württemberg, Germany, 79106 Heart Center Bad Neustadt Recruiting Bad Neustadt An Der Saale, Bayern, Germany, 97616 Contact: Arno Diegeler, Prof., MD          Contact: Wilko Reents, MD          University of Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Rüdiger Autschbach, MD, Prof.          Sub-Investigator: Andreas Goetzenich, MD          Principal Investigator: Rüdiger Autschbach, MD, Prof.          Heart Center Bad Oeynhausen Recruiting Bad Oeynhausen, NRW, Germany, 32545 Contact: Jan Gummmert, MD, Prof.          Principal Investigator: Jochen Börgermann, MD, PhD          Principal Investigator: Jan Gummert, MD, Prof.          University of Bochum Recruiting Bochum, NRW, Germany Contact: Justus Strauch, MD, Prof.          Principal Investigator: Mügge, MD, Prof.          Sub-Investigator: Peter Haldenwang, MD          University of Bonn Active, not recruiting Bonn, NRW, Germany, 53127 University of Cologne Recruiting Cologne, NRW, Germany, 50924 Contact: Oliver J Liakopoulos, MD, PhD    +49 221 478 ext 32450    oliver.liakopoulos@uk-koeln.de    Principal Investigator: Oliver J Liakopoulos, MD, PhD          Principal Investigator: Thorsten Wahlers, MD, Prof.          University of Essen Recruiting Essen, NRW, Germany, 45122 Contact: Matthias Thielmann, MD, PhD          Principal Investigator: Matthias Thielmann, MD, PhD          Principal Investigator: Heinz Jakob, MD, Prof.          Sub-Investigator: Daniel Wendt, MD          University of Muenster Active, not recruiting Muenster, NRW, Germany, 48149 Helios Heart Center Wuppertal Active, not recruiting Wuppertal, NRW, Germany, 42117 Less <<
NCT00730132 - Completed - -
NCT00718796 Cardiovascular Disease Phase 3 Completed - Canada, Ontario ... More >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 Less <<
NCT01483950 - Completed - Bosnia and Herzegovina ... More >> Research Site Banja Luka, Bosnia and Herzegovina Research Site Bijeljina, Bosnia and Herzegovina Research Site Doboj, Bosnia and Herzegovina Reserach Site Gradiška, Bosnia and Herzegovina Research Site Kakanj, Bosnia and Herzegovina Research Site Maglaj, Bosnia and Herzegovina Research Site Prijedor, Bosnia and Herzegovina Research Site Sarajevo, Bosnia and Herzegovina Research Site Tešanj, Bosnia and Herzegovina Research Site Trebinje, Bosnia and Herzegovina Research Site Visoko, Bosnia and Herzegovina Research Site Zavidovići, Bosnia and Herzegovina Research Site Zenica, Bosnia and Herzegovina Research Site Zvornik, Bosnia and Herzegovina Less <<
NCT01377909 Chronic Hepatitis C Phase 1 Terminated(Principal Investiga... More >>tor retiring) Less << - United States, Oklahoma ... More >> Veterans Administration Medical Center (VAMC) Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00407680 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Unknown March 2009 Japan ... More >> Kitasato University Recruiting 1-15-1 Kitasato Sagamihara, Kanagawa, Japan, 228-8111 Contact: Keiji Tanaka    +81-427-8111 ext 8706    keiji@med.kitasato-u.ac.jp    Principal Investigator: Keiji Tanaka, Keiji Tanaka Less <<
NCT00309257 Alport Syndrome Phase 2 Completed - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT01045512 Aging Inflamm... More >>ation Less << Phase 2 Terminated(unsufficient recrui... More >>tment) Less << - Germany ... More >> Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Klinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle (Saale), Ernst-Grube-Strasse 40 Halle (Saale), Sachsen-Anhalt, Germany, 06097 Less <<
NCT00176410 Aortic Valve Stenosis Phase 2 Unknown December 2009 Germany ... More >> University of Leipzig - Heart Center Recruiting Leipzig, Saxony, Germany, 04289 Contact: Claudia Walther, MD    xx49-341-8651428    waltherc@medizin.uni-leipzig.de    Sub-Investigator: Claudia A Walther, MD Less <<
NCT00223015 Renal Transplantation Phase 4 Completed - -
NCT01524601 Disorder Related to Renal Tran... More >>splantation Hypercholesterolemia Less << Phase 4 Completed - Norway ... More >> Oslo University Hospital, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT00127218 - Completed - -
NCT01992042 Prostate Cancer Phase 2 Completed - Canada, Ontario ... More >> University Health Network- The Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G2M9 Less <<
NCT00730132 - Completed - -
NCT00223028 Renal Transplantation Phase 4 Completed - -
NCT00821574 Hypertension, Dyslypidaemia Phase 4 Completed - -
NCT00385658 Dyslipidemia Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharma AG Basel, Switzerland Less <<
NCT00171288 Dyslipidemia Phase 3 Completed - Spain ... More >> Novartis Madrid, Spain Less <<
NCT00199927 Chronic Nephropathy ... More >> Proteinuria Hypertension Less << Phase 3 Completed - Italy ... More >> Hospital "Santa Maria della Gruccia" - Unit of Nephrology and Dialysis Montevarchi, Arezzo, Italy, 52100 Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Hospital "S.Marte e S.Venere" - Unit of Nephrology and Dialysis Acireale, Catania, Italy, 95024 Hospital "Santa Maria dell'Annunziata" - Unit of Nephrology Bagno a Ripoli, Firenze, Italy, 50011 Hospital "Casa Sollievo della Sofferenza" - Unit of Nephrology and Dialysis San Giovanni Rotondo, Foggia, Italy, 71013 Hospital "S.Giacomo Apostolo" Castelfranco Veneto, Treviso, Italy, 31033 Hospital "Vittorio Emanuele II, S. Bambino, Ferrarotto" - Unit of Nephrology and Dialisys Catania, Italy, 95100 Hospital "Ciaccio" - Unit of Nephrolofy and Dialysis Catanzaro, Italy, 88100 Hospital "Careggi Monna Tessa" - Unit of Nephrology and Dialysis Firenze, Italy Hospital of Padova - Unit of Nephrology and Dialysis Padova, Italy, 31033 Hospital "Civico e Benefratelli" - Unit of Nephrology and Hemodialysis Palermo, Italy, 90100 Hospital of Parma - Department of Medical Clinic Parma, Italy, 43100 "Ospedali Riuniti" CNR I.B.I.M. - Unit of Nephrology Reggio Calabria, Italy, 89124 University of Sassari - Institute of Medical Pathology Sassari, Italy, 07100 Hospital "G.Mazzini" - Unit of Nephrology and Dialysis Teramo, Italy, 64100 Hospital of Mestre - Unit of Nephrology and Dialysis Venezia, Italy, 30174 Less <<
NCT00465322 - Completed - Switzerland ... More >> Cardiology University Hospital Bern, Switzerland, 3010 Less <<
NCT00125125 Dyslipidemia Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00489424 - Completed - -
NCT00549926 Coronary Disease ... More >> Hypercholesterolemia Less << Phase 4 Completed - Japan ... More >> Yokohama City University Medical Center Yokohama, Japan Less <<
NCT00171275 Coronary Disease ... More >> Myocardial Infarction Less << Phase 4 Completed - Czech Republic ... More >> Novartis Praha, Czech Republic Less <<
NCT00171327 Hypertension ... More >>Dyslipidemia Less << Phase 4 Completed - Russian Federation ... More >> Novartis Moscow, Russian Federation Less <<
NCT00136799 Mixed Dyslipidemia ... More >> Hypercholesterolemia Less << Phase 3 Completed - China ... More >> Novartis Shangai, China Less <<
NCT03309618 Myocardial Infarction Not Applicable Completed - Slovenia ... More >> Department of Vascular Diseases, University Medical Centre Ljubljana Ljubljana, Slovenia, SI-1000 Less <<
NCT00171236 Heterozygous Familial Hypercho... More >>lesterolemia Mixed Dyslipidemia Less << Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00223041 Renal Transplantation Phase 2 Phase 3 Terminated(No possibilty to re... More >>ceive all plened patients for this study) Less << - Germany ... More >> University of Schleswig-Holstein, Campus Kiel, Department of Nephrology Kiel, Germany, 24251 Less <<
NCT03393377 Atherosclerosis Not Applicable Completed - -
NCT00171262 Dyslipidemia Phase 4 Completed - Spain ... More >> Novartis Madrid, Spain Less <<
NCT00382161 Impotence Phase 3 Withdrawn(not enough patients ... More >>meeting inclusion criteria) Less << December 2007 Germany ... More >> University Hospital of the Saarland Homburg, Saarland, Germany, 66421 Less <<
NCT00138528 Metabolic Syndrome Phase 4 Completed - Germany ... More >> Novartis Nürnberg, Germany Less <<
NCT00441493 Hepatitis C Not Applicable Completed - United States, Oklahoma ... More >> VA Medical Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00416403 Breast Cancer Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115-6084 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00814606 Hepatitis C H... More >>epatitis C Virus Less << Phase 2 Withdrawn(no one ever enrolled... More >>) Less << - -
NCT00565474 Graft Vasculopathy Phase 4 Completed - Spain ... More >> Novartis Investigative Site Barcelona, Spain Less <<
NCT00421005 Heart Transplantation ... More >> Hypercholesterolemia Less << Phase 4 Unknown November 2008 Italy ... More >> Policlinico S.Orsola-Malpighi Bologna, Italy, 40138 Less <<
NCT00404287 Aortic Valve Stenosis Phase 4 Suspended(Funding not enough t... More >>o complete the study) Less << January 2018 Spain ... More >> Hospital Universitario de Salamanca Salamanca, Spain, 37002 Less <<
NCT00752843 Healthy Subjects Phase 1 Completed - United States, Arizona ... More >> MDS Pharma Tempe, Arizona, United States, 85283 Less <<
NCT02115074 Glioma Phase 1 Recruiting October 2022 France ... More >> CHU Angers Suspended Angers, France, 49933 Centre Hospitalier de Bordeaux - Hôpital des Enfants Not yet recruiting Bordeaux, France, 33076 Contact: Céline ICHER, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Pierre LEBLOND, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Cécile FAURE-CONTER, MD          Hôpital pour enfants La Timone Recruiting Marseille, France, 13385 Contact: André NICOLAS, MD          Centre Hospitalier de Nantes - Hôpital Mère enfants Not yet recruiting Nantes, France, 44000 Contact: Sophie DUMOUCEL, MD          Institut Curie Recruiting Paris, France, 75005 Contact: Isabelle AERTS, MD          Centre Hospitalier de Strasbourg Not yet recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ WERLE, MD          Centre Hospitalier de Purpan - Hôpital des Enfants Recruiting Toulouse, France, 31026 Contact: Anne-Isabelle BERTOZZI, MD          Centre Hospitalier de Nancy Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Pascal CHASTAGNER, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Jacques GRILL, MD Less <<
NCT00664742 Metabolic Syndrome Phase 4 Completed - Turkey ... More >> Götzepe Education and Research Hospital Istanbul, Turkey Less <<
NCT00487318 Chronic Hepatitis C Phase 2 Completed - United States, Oklahoma ... More >> Veterans Administration Medical Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00814723 Hypercholesterolemia Phase 4 Completed - Austria ... More >> Depart. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT00674297 Antiphospholipid Syndrome Phase 2 Completed - United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 United States, Texas Division of Rheumatology, University of Texas Medical Branch Galveston, Texas, United States, 77555 Less <<
NCT00489424 Osteoporosis Phase 4 Completed - United States, New Jersey ... More >> Refer to the E-portal link for ZOL446HUS136 Http://www.osteoporosisclinicalresearch.com, New Jersey, United States Less <<
NCT03189511 Adipose Tissue, Brown ... More >> Insulin Resistance Clinical Trial Less << Phase 4 Completed - Switzerland ... More >> University Hospital of Zurich, PET/MR Center Schlieren, Zurich, Switzerland, 8952 University Hospital of Basel Basel, Switzerland, 4031 Less <<
NCT00674297 - Completed - -
NCT01551173 Lipid Metabolism Disorders PHASE4 COMPLETED 2025-05-13 Novartis Investigative Site, C... More >>hangsha, Hunan, 410011, China Less <<
NCT01551173 Lipid Metabolism Disorders PHASE4 COMPLETED 2025-05-13 Novartis Investigative Site, C... More >>hangsha, Hunan, 410011, China Less <<
NCT00664742 - Completed - -
NCT01681199 Coronary Heart Disease ... More >> Atherosclerosis Less << Phase 4 Unknown August 2014 China, Beijing ... More >> Cardiology department ,Beijing Anzhen hospital Recruiting Beijing, Beijing, China, 100029 Contact: Xin Du, PhD    86 15010519643    duxinheart@sina.com    Sub-Investigator: Xin Du, PhD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.54mL

2.31mL

1.15mL

23.07mL

4.61mL

2.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories